Costs of Care and Adherence to Treatment for Cystic Fibrosis

Evolution of medical care for patients with cystic fibrosis appeared in recent years: prolongation of life expectancy with consequently increased comorbidities and the use of lung transplantation, systematic neonatal screening of new born since 2002, prescription of expensive new molecules or new presentation. This evolution justifies to realize an update of statistics of costs of care and to assess adherence to treatment

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cystic Fibrosis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Digestive System Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Lung Diseases Pancreatic Diseases Respiratory Tract Diseases

Age range

Up to 99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospices civils de Lyon, centre hospitalier lyon Sud

Pierre-Bénite, 69310, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with cystic fibrosis,
Followed by one of the cystic fibrosis center of the Rhône-Alpes region (pediatric and adult of Lyon and Grenoble)
Affiliated to the general scheme of health insurance,
And domiciled in the Rhône-Alpes region.

Exclusion criteria

Transplanted patients

Treatment and study plan

Primary outcomes

treatment cost

Time frame: 12 months

Secondary outcomes

adherence rate for chronic treatment

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Costs of Care and Adherence to Treatment for Cystic Fibrosis.

Acronym: COMURA MUCOBS

Important dates

Study start: 2014
Primary completion: 2016
Study completion: 2016
First posted: Jul 14, 2016
Registry last updated: Aug 10, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed